{"schema_version":"secwatch.filing_event.v1","accession":"0001773751-26-000074","form_type":"8-K","ticker":"HIMS","cik":"0001773751","company_name":"Hims & Hers Health, Inc.","filed_at":"2026-05-11T20:08:27+00:00","discovered_at":"2026-05-11T20:10:00.393739+00:00","generated_at":"2026-05-11T22:31:02.952944+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Hims & Hers Q1 net loss $92.1M; revenue $608M (+4% YoY); raises FY2026 guidance to $2.8B-$3.0B","bullets":["Revenue $608.1M (+4% YoY); net loss $92.1M vs net income $49.5M in Q1 2025.","Adjusted EBITDA $44.3M vs $91.1M; gross margin fell to 65% from 73%.","Subscribers 2.584M (+9% YoY); monthly revenue per subscriber $80 (-6%).","FY2026 revenue guidance raised to $2.8B–$3.0B; Adjusted EBITDA guidance $275M–$350M.","Proposed acquisition of Eucalyptus expected mid-2026; not included in guidance."],"urls":{"canonical":"https://secwatch.observer/filing/0001773751-26-000074","json":"https://secwatch.observer/filing/0001773751-26-000074.json","markdown":"https://secwatch.observer/filing/0001773751-26-000074.md","text":"https://secwatch.observer/filing/0001773751-26-000074.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1773751/000177375126000074/0001773751-26-000074-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1773751/000177375126000074/hims-20260511.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-11T22:31:02.952944+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8e0f4179a781b9b745f40e84e1fe43689eafba98","claim":"Hims & Hers Health, Inc. reported the first quarter ended March 31, 2026 results: revenue $608.1 million, net income $92.1 million. Guidance raised.","evidence_excerpt":"Hims & Hers Health, Inc. Reports First Quarter 2026 Financial Results Revenue of approximately $608 million, up 4% year-over-year in Q1 2026","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1773751/000177375126000074/0001773751-26-000074-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the first quarter ended March 31, 2026"},{"label":"Revenue","value":"$608.1 million"},{"label":"Net income","value":"$92.1 million"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}